HomeBUSINESS
BUSINESS

Shionogi Initiates Rolling NDA Submission in US for Lusutrombopag
(Sep.26.2017)

Shionogi said on September 25 that it has initiated a rolling new drug application submission in the US for its small molecule thrombopoietin receptor agonist lusutrombopag for the treatment of thrombocytopenia ...
(LOG IN FOR FULL STORY)

News Calendar